Kamagra Oral Jelly (Ajanta Pharma Ltd., Mumbai, India) is a highly effective drug designed to increase male potency. The active ingredient of the drug is sildenafil citrate.
Kamagra Oral Jelly is available in the form of sachets with a jelly-like filling available in different flavors. The use of this form of medicine avoids unpleasant taste sensations and increases the rate of absorption of the active substance into the blood in comparison with the intake of tablets.
The manufacturer of Kamagra Oral Jelly, Ajanta Pharma Ltd., is one of the leaders in the market of potency regulators for the treatment of sexual disorders in men. Due to its high quality and affordable price, Kamagra Oral Jelly is one of the leading products in terms of sales revenue among medications for the treatment of erectile dysfunction, both in several European countries and in the United States.
Dosage and usage
One sachet of this product contains a daily dose of sildenafil citrate, which is 100 mg. Importantly, it is not recommended to exceed this dose. The effect of Kamagra Oral Jelly is achieved already at the first dose, at 15 minutes to 30 minutes after consumption.
Patients should remember that sexual stimulation is necessary for an erection to occur. The contents of one sachet should be placed in the oral cavity under the tongue and swallowed up after a few minutes.
Before buying and using Kamagra Oral Jelly, patients should carefully read the instructions for the use of the drug and consult their doctor about the possibility of using Kamagra as well as potential contraindications and side effects associated with its consumption.
The drug should not be taken if the patient has experienced an allergic reaction or intolerance to sildenafil citrate. Kamagra Oral Jelly is forbidden in patients with severe diseases of the heart and blood vessels in the stage of decompensation, angina, myocardial infarction, or ischemic stroke.
It is not recommended that this drug is used by individuals with uncontrolled arterial hypertension or severe arterial hypotension. In severe, life-threatening disorders of the heart rhythm and in severe forms of liver or kidney failure, the drug is also contraindicated.
Patients with penile deformities or priapism, hereditary pigmentary retinitis, peptic ulcer, and/or an increased tendency for bleeding should additionally not take this medication. The drug is prohibited from being used by people under the age of 18 years.
Interaction with other drugs
It is strictly forbidden to take Kamagra Oral Jelly in conjunction with treatment with nitro-containing drugs, nicorandil, and alpha-blockers, as such combinations may cause a sharp, uncontrolled drop in blood pressure.
Patients should not take Kamagra Oral Jelly if they are being treated using ketoconazole, itraconazole, fluconazole, erythromycin, clarithromycin, or cimetidine, as this may cause an overdose. The interval between taking sildenafil and these medications should be at least 72 hours.
It is forbidden to combine this medication with other drugs based on cGMP inhibitors. It is not recommended to take Kamagra with grapefruit juice because of the juice’s ability to increase the content of the active substance in the blood plasma, which may lead to the onset of overdose symptoms.
In the case of compliance of the recommended dosage of Kamagra, side effects are rare. However, the drug can cause a headache, dizziness, lower blood pressure, impaired color perception, reduced visual clarity, nasal congestion, and dyspeptic symptoms (e.g., nausea and discomfort in the epigastric region). These phenomena usually resolve on their own and do not require a visit to a doctor.